Adisa, R, Alutundu, MB and Fakeye, TO (2009) Factors contributing to nonadherence to oral hypoglycemic medications among ambulatory type 2 diabetes patients in Southwestern Nigeria. Pharmacy Practice (Granada) 7, 163–169.
Al-Sukhni, M, Maruschak, NA and McIntyre, RS (2015) Vortioxetine: a review of efficacy, safety and tolerability with a focus on cognitive symptoms in major depressive disorder. Expert Opinion on Drug Safety 14, 1291–1304.
Argyropoulos, SV and Nutt, DJ (2013) Anhedonia revisited: is there a role for dopamine-targeting drugs for depression? Journal of Psychopharmacology 27, 869–877.
Bonde, JP (2008) Psychosocial factors at work and risk of depression: a systematic review of the epidemiological evidence. Occupational & Environmental Medicine 65, 438–445.
Chan, SM, Chiu, FK, Lam, CW, Wong, SM and Conwell, Y (2014) A multidimensional risk factor model for suicide attempts in later life. Neuropsychiatric Disease Treatment 10, 1807–1817.
Cheng, IC, Liao, SC, Lee, MB and Tseng, MM (2007) Predictors of treatment response and length of stay for inpatients with major depression. Journal of Formosan Medical Association 106, 903–910.
Coenen, P, Willenberg, L, Parry, S, Shi, JW, Romero, L, Blackwood, DM, Maher, CG, Healy, GN, Dunstan, DW and Straker, LM (2016) Associations of occupational standing with musculoskeletal symptoms: a systematic review with meta-analysis. British Journal of Sports Medicine 52, 176–183.
Couser, GP (2008) Challenges and opportunities for preventing depression in the workplace: a review of the evidence supporting workplace factors and interventions. Journal of Occupational & Environmental Medicine 50, 411–427.
Drago, A and Serretti, A (2011) Sociodemographic features predict antidepressant trajectories of response in diverse antidepressant pharmacotreatment environments: a comparison between the STAR*D study and an independent trial. Journal of Clinical Psychopharmacology 31, 345–348.
Ekman, M, Granstrom, O, Omerov, S, Jacob, J and Landen, M (2013) The societal cost of bipolar disorder in Sweden. Social Psychiatry and Psychiatric Epidemiology 48, 1601–1610.
Evans-Lacko, S and Knapp, M (2016) Global patterns of workplace productivity for people with depression: absenteeism and presenteeism costs across eight diverse countries. Social Psychiatry and Psychiatric Epidemiology 51, 1525–1537.
Fava, M (2006) Pharmacological approaches to the treatment of residual symptoms. Journal of Psychopharmacology 20, 29–34.
Fava, GA, Fabbri, S and Sonino, N (2002) Residual symptoms in depression: an emerging therapeutic target. Progress in Neuro-Psychopharmacology & Biological Psychiatry 26, 1019–1027.
Frank, E (1997) Enhancing patient outcomes: treatment adherence. Journal of Clinical Psychiatry 58 Suppl 1, 11–14.
Fryers, T, Melzer, D and Jenkins, R (2003) Social inequalities and the common mental disorders: a systematic review of the evidence. Social Psychiatry and Psychiatric Epidemiology 38, 229–237.
Harmer, CJ (2008) Serotonin and emotional processing: does it help explain antidepressant drug action? Neuropharmacology 55, 1023–1028.
Hawksley, B (2007) Work-related stress, work/life balance and personal life coaching. British Journal of Community Nursing 12, 34–36.
Hollingshead, AB (1975) Four Factor Index of Social Position. New Haven, CT: Department of Sociology, Yale University.
Jakubovski, E and Bloch, MH (2014) Prognostic subgroups for citalopram response in the STAR*D trial. Journal of Clinical Psychiatry 75, 738–747.
Judge, TA, Bono, JE, Ilies, R and Gerhardt, MW (2002) Personality and leadership: a qualitative and quantitative review. Journal of Applied Psychology 87, 765–780.
Keefe, RS, McClintock, SM, Roth, RM, Doraiswamy, PM, Tiger, S and Madhoo, M (2014) Cognitive effects of pharmacotherapy for major depressive disorder: a systematic review. Journal of Clinical Psychiatry 75, 864–876.
Kennedy, N and Foy, K (2005) The impact of residual symptoms on outcome of major depression. Current Psychiatry Reports 7, 441–446.
Kessler, RC, Berglund, P, Demler, O, Jin, R, Koretz, D, Merikangas, KR, Rush, AJ, Walters, EE and Wang, PS (2003) The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289, 3095–3105.
Kessler, RC, Chiu, WT, Demler, O, Merikangas, KR and Walters, EE (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 62, 617–627.
Malpass, A, Shaw, A, Sharp, D, Walter, F, Feder, G, Ridd, M and Kessler, D (2009) ‘Medication career’ or ‘moral career’? The two sides of managing antidepressants: a meta-ethnography of patients’ experience of antidepressants. Social Science & Medicine 68, 154–168.
Mandelli, L, Serretti, A, Souery, D, Mendlewicz, J, Kasper, S, Montgomery, S and Zohar, J (2016) High occupational level is associated with poor response to treatment of depression. European Neuropsychopharmacology 26, 1320–1326.
Marutani, T, Yahata, N, Ikeda, Y, Ito, T, Yamamoto, M, Matsuura, M, Matsushima, E, Okubo, Y, Suzuki, H and Matsuda, T (2011) Functional magnetic resonance imaging study on the effects of acute single administration of paroxetine on motivation-related brain activity. Psychiatry & Clinical Neuroscience 65, 191–198.
Mathers, CD, Salomon, JA, Ezzati, M, Begg, S, Hoorn, SV and Lopez, AD (2006) Sensitivity and uncertainty analyses for burden of disease and risk factor estimates. In Lopez, AD, Mathers, CD, Ezzati, M, Jamison, DT and Murray, CJL (eds), Global Burden of Disease and Risk Factors, pp. 399–426. Washington, DC: Oxford University Press.
McCabe, C, Mishor, Z, Cowen, PJ and Harmer, CJ (2010) Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. Biological Psychiatry 67, 439–445.
McIntyre, RS, Xiao, HX, Syeda, K, Vinberg, M, Carvalho, AF, Mansur, RB, Maruschak, N and Cha, DS (2015) The prevalence, measurement, and treatment of the cognitive dimension/domain in major depressive disorder. CNS Drugs 29, 577–589.
Milner, A, Spittal, MJ, Pirkis, J and LaMontagne, AD (2013) Suicide by occupation: systematic review and meta-analysis. British Journal of Psychiatry 203, 409–416.
Modini, M, Joyce, S, Mykletun, A, Christensen, H, Bryant, RA, Mitchell, PB and Harvey, SB (2016) The mental health benefits of employment: results of a systematic meta-review. Australasian Psychiatry 24, 331–336.
Montejo, AL (2009) Toward depression remission: balancing efficacy and tolerability. Journal of Clinical Psychiatry 70, e36.
Mrazek, DA, Hornberger, JC, Altar, CA and Degtiar, I (2014) A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996–2013. Psychiatric Services 65, 977–987.
Muntaner, C, Eaton, WW, Miech, R and O'Campo, P (2004) Socioeconomic position and major mental disorders. Epidemiologic Reviews 26, 53–62.
Papakostas, GI and Culpepper, L (2015) Understanding and managing cognition in the depressed patient. Journal of Clinical Psychiatry 76, 418–425.
Ridge, D, Kokanovic, R, Broom, A, Kirkpatrick, S, Anderson, C and Tanner, C (2015) ‘My dirty little habit’: patient constructions of antidepressant use and the ‘crisis’ of legitimacy. Social Science & Medicine 146, 53–61.
Rusch, N, Angermeyer, MC and Corrigan, PW (2005) Mental illness stigma: concepts, consequences, and initiatives to reduce stigma. European Psychiatry 20, 529–539.
Serretti, A and Chiesa, A (2009) Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. Journal of Clinical Psychopharmacology 29, 259–266.
Serretti, A and Mandelli, L (2010) Antidepressants and body weight: a comprehensive review and meta-analysis. Journal of Clinical Psychiatry 71, 1259–1272.
Serretti, A, Calati, R, Goracci, A, Di Simplicio, M, Castrogiovanni, P and De Ronchi, D (2010) Antidepressants in healthy subjects: what are the psychotropic/psychological effects? European Neuropsychopharmacology 20, 433–453.
Shannonhouse, JL, DuBois, DW, Fincher, AS, Vela, AM, Henry, MM, Wellman, PJ, Frye, GD and Morgan, C (2016) Fluoxetine disrupts motivation and GABAergic signaling in adolescent female hamsters. Progress in Neuro-Psychopharmacology & Biological Psychiatry 69, 19–30.
Shelton, RC, Tollefson, GD, Tohen, M, Stahl, S, Gannon, KS, Jacobs, TG, Buras, WR, Bymaster, FP, Zhang, W, Spencer, KA, Feldman, PD and Meltzer, HY (2001) A novel augmentation strategy for treating resistant major depression. American Journal of Psychiatry 158, 131–134.
Stahl, SM (2015) Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): actions at serotonin receptors may enhance downstream release of four pro-cognitive neurotransmitters. CNS Spectrums 20, 515–519.
Sudak, H, Maxim, K and Carpenter, M (2008) Suicide and stigma: a review of the literature and personal reflections. Academic Psychiatry 32, 136–142.
Tennant, C (2001) Work-related stress and depressive disorders. Journal of Psychosomatic Research 51, 697–704.
Theorell, T, Hammarstrom, A, Aronsson, G, Traskman Bendz, L, Grape, T, Hogstedt, C, Marteinsdottir, I, Skoog, I and Hall, C (2015) A systematic review including meta-analysis of work environment and depressive symptoms. BMC Public Health 15, 738.
Thomas, C and Morris, S (2003) Cost of depression among adults in England in 2000. British Journal of Psychiatry 183, 514–519.
Tseng, MC, Cheng, IC, Lee, YJ and Lee, MB (2006) Intermediate-term outcome of psychiatric inpatients with major depression. Journal of the Formosan Medical Association 105, 645–652.
van der Lem, R, Stamsnieder, PM, van der Wee, NJ, van Veen, T and Zitman, FG (2013) Influence of sociodemographic and socioeconomic features on treatment outcome in RCTs versus daily psychiatric practice. Social Psychiatry and Psychiatric Epidemiology 48, 975–984.
Wada, K, Eguchi, H, Prieto-Merino, D and Smith, DR (2016) Occupational differences in suicide mortality among Japanese men of working age. Journal of Affective Disorders 190, 316–321.
Yee, A, Chin, SC, Hashim, AH, Harbajan Singh, MK, Loh, HS, Sulaiman, AH and Ng, CG (2015) Anhedonia in depressed patients on treatment with selective serotonin reuptake inhibitor anti-depressant – a two-centered study in Malaysia. International Journal of Psychiatry in Clinical Practice 19, 182–187.